| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.07 | 0.2 |